Junna Oba

Scopus著者プロファイル

ウェブサイトhttps://k-ris.keio.ac.jp/html/100015206_ja.html

h-index

年別の研究成果

Pureに変更を加えた場合、すぐここに表示されます。

フィンガープリント

Junna Obaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。

1 類似のプロファイル

31 Article
3 Letter
2 Review article
1 Comment/debate

Multi-modal molecular programs regulate melanoma cell state
Andrews, M. C., Oba, J., Wu, C. J., Zhu, H., Karpinets, T., Creasy, C. A., Forget, M. A., Yu, X., Song, X., Mao, X., Robertson, A. G., Romano, G., Li, P., Burton, E. M., Lu, Y., Sloane, R. S., Wani, K. M., Rai, K., Lazar, A. J., Haydu, L. E., & 16 othersBustos, M. A., Shen, J., Chen, Y., Morgan, M. B., Wargo, J. A., Kwong, L. N., Haymaker, C. L., Grimm, E. A., Hwu, P., Hoon, D. S. B., Zhang, J., Gershenwald, J. E., Davies, M. A., Futreal, P. A., Bernatchez, C. & Woodman, S. E., 2022 12月, In: Nature communications. 13, 1, 4000.
研究成果: Article › 査読

Open Access
5 被引用数 (Scopus)
SARS-CoV-2 RT-qPCR testing of pooled saliva samples: A case study of 824 asymptomatic individuals and a questionnaire survey in Japan
Oba, J., Taniguchi, H., Sato, M., Takanashi, M., Yokemura, M., Sato, Y. & Nishihara, H., 2022 5月, In: PloS one. 17, 5 May, e0263700.
研究成果: Article › 査読

Open Access
Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
Nakamura, K., Aimono, E., Oba, J., Hayashi, H., Tanishima, S., Hayashida, T., Chiyoda, T., Kosaka, T., Hishida, T., Kawakubo, H., Kitago, M., Okabayashi, K., Funakoshi, T., Okita, H., Ikeda, S., Takaishi, H. & Nishihara, H., 2021 4月, In: Medical Oncology. 38, 4, 36.
研究成果: Article › 査読

Open Access
13 被引用数 (Scopus)
Pulmonary metastasis secondary to abiraterone-resistant prostate cancer with homozygous deletions of BRCA2: First Japanese case
Izawa, M., Kosaka, T., Nakamura, K., Oba, J., Hishida, T., Hongo, H., Mikami, S., Nishihara, H. & Oya, M., 2021 1月, In: IJU Case Reports. 4, 1, p. 14-17 4 p.
研究成果: Article › 査読

Open Access
3 被引用数 (Scopus)
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy
Terranova, C. J., Tang, M., Maitituoheti, M., Raman, A. T., Ghosh, A. K., Schulz, J., Amin, S. B., Orouji, E., Tomczak, K., Sarkar, S., Oba, J., Creasy, C., Wu, C. J., Khan, S., Lazcano, R., Wani, K., Singh, A., Barrodia, P., Zhao, D., Chen, K., & 6 othersHaydu, L. E., Wang, W. L., Lazar, A. J., Woodman, S. E., Bernatchez, C. & Rai, K., 2021 7月 20, In: Cell Reports. 36, 3, 109410.
研究成果: Article › 査読

Open Access
12 被引用数 (Scopus)

大場純奈

フィンガープリント

過去5年の共同研究と上位研究分野

詳細を開く

Multi-modal molecular programs regulate melanoma cell state

SARS-CoV-2 RT-qPCR testing of pooled saliva samples: A case study of 824 asymptomatic individuals and a questionnaire survey in Japan

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

Pulmonary metastasis secondary to abiraterone-resistant prostate cancer with homozygous deletions of BRCA2: First Japanese case

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

大場 純奈

フィンガープリント

過去5年の共同研究と上位研究分野

研究成果

Multi-modal molecular programs regulate melanoma cell state

SARS-CoV-2 RT-qPCR testing of pooled saliva samples: A case study of 824 asymptomatic individuals and a questionnaire survey in Japan

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status

Pulmonary metastasis secondary to abiraterone-resistant prostate cancer with homozygous deletions of BRCA2: First Japanese case

Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategy

大場純奈